ScholarWorks@Gyeongsang National University

Browsing by Kim, Hye RyunAuthor

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 6 of 6

SCIESCOPUS
A Phase 1/2 Study of Lazertinib 240 mg in Patients With Advanced EGFR T790M-Positive NSCLC After Previous EGFR Tyrosine Kinase Inhibitors

Cho, Byoung Chul; Han, Ji-Youn; Kim, Sang-We; Lee, Ki Hyeong; Cho, Eun Kyung; Lee, Yun-Gyoo; Kim, Dong-Wan; Kim, Joo-Hang; Lee, Gyeong-Won; Lee, Jong-Seok, et al.

ArticleIssue Date2022CitationJournal of Thoracic Oncology, v.17, no.4, pp 558 - 567PublisherElsevier Inc.
SCIESCOPUSKCI
A Randomized, Open-Label, Phase II Study Comparing Pemetrexed Plus Cisplatin Followed by Maintenance Pemetrexed versus Pemetrexed Alone in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer after Failure of First-Line EGFR Tyrosine Kinase Inhibitor: KCSG-LU12-13open access

Yoo, Kwai Han; Lee, Su Jin; Cho, Jinhyun; Lee, Ki Hyeong; Park, Keon Uk; Kim, Ki Hwan; Cho, Eun Kyung; Choi, Yoon Hee; Kim, Hye Ryun; Kim, Hoon-Gu, et al.

ArticleIssue Date2019CitationCANCER RESEARCH AND TREATMENT, v.51, no.2, pp 718 - 726PublisherKOREAN CANCER ASSOCIATION
SCIESCOPUS
Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1-2 study

Ahn, Myung-Ju; Han, Ji-Youn; Lee, Ki Hyeong; Kim, Sang-We; Kim, Dong-Wan; Lee, Yun-Gyoo; Cho, Eun Kyung; Kim, Joo-Hang; Lee, Gyeong-Won; Lee, Jong-Seok, et al.

ArticleIssue Date2019CitationLANCET ONCOLOGY, v.20, no.12, pp 1681 - 1690PublisherELSEVIER SCIENCE INC
SCIESCOPUS
Mycobacterium tuberculosis-specific T cells restrain anti-cancer drug-induced neutrophilic lung inflammation in tuberculosisopen access

Kwon, Kee Woong; Kang, Tae Gun; Lee, Jii Bum; Choi, Eunsol; Kim, Hagyu; Park, Min Chul; Choi, Sangwon; Kim, Kyungmin; Kim, Hyeong Woo; Jeong, Su Jin, et al.

ArticleIssue Date2025CitationNature Communications, v.16, no.1PublisherNature Publishing Group
SCIESCOPUS
Phase 2 study of afatinib among patients with recurrent and/or metastatic esophageal squamous cell carcinoma

Hong, Min Hee; Heo, Seong Gu; Lee, Yun-Gyoo; Kim, Hyo Song; Park, Keon Uk; Kim, Hoon-Gu; Ko, Yoon Ho; Chung, Ik-Joo; Min, Young Joo; Kim, Min Kyoung, et al.

ArticleIssue Date2020CitationCancer, v.126, no.20, pp 4521 - 4531PublisherJohn Wiley & Sons Inc.
SCIESCOPUS
Pragmatic nationwide master observational trial based on genomic alterations in advanced solid tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS)-II study protocol KCSG AL-22-09open access

Kim, Sun Young; Kim, Jee Hyun; Kim, Tae-Yong; Park, Sook Ryun; Yoon, Shinkyo; Lee, Soohyeon; Lee, Se-Hoon; Kim, Tae Min; Han, Sae-Won; Kim, Hye Ryun, et al.

ArticleIssue Date2024CitationBMC Cancer, v.24, no.1PublisherBioMed Central
1

RSS_1.0 RSS_2.0 ATOM_1.0

Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532

COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어